Polatuzumab-vedotin
Jun 13, 2019•13 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
A newly approved drug for relapsed/refractory diffuse large B-cell lymphoma is discussed as well as PBR.
For the best experience, listen in Metacast app for iOS or Android